1. Home
  2. MHO vs IDYA Comparison

MHO vs IDYA Comparison

Compare MHO & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MHO

M/I Homes Inc.

HOLD

Current Price

$135.27

Market Cap

3.5B

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$35.99

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MHO
IDYA
Founded
1976
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
2.9B
IPO Year
1986
2019

Fundamental Metrics

Financial Performance
Metric
MHO
IDYA
Price
$135.27
$35.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
14
Target Price
$157.00
$49.67
AVG Volume (30 Days)
174.0K
838.8K
Earning Date
01-28-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
17.05
N/A
Revenue
$4,475,753,000.00
$214,834,000.00
Revenue This Year
N/A
$2,688.43
Revenue Next Year
N/A
N/A
P/E Ratio
$8.11
N/A
Revenue Growth
4.77
5377.66
52 Week Low
$100.22
$13.45
52 Week High
$158.92
$39.28

Technical Indicators

Market Signals
Indicator
MHO
IDYA
Relative Strength Index (RSI) 53.04 52.93
Support Level $132.06 $34.67
Resistance Level $140.15 $37.81
Average True Range (ATR) 4.41 1.78
MACD 0.47 -0.12
Stochastic Oscillator 64.85 50.22

Price Performance

Historical Comparison
MHO
IDYA

About MHO M/I Homes Inc.

M/I Homes Inc is an American construction company that focuses on residential construction. It consists of two distinct operations: homebuilding and financial services. The homebuilding operations are spread into the Midwest, Mid-Atlantic, and Southern regions, and the financial services operations support homebuilding operations by providing mortgage loans and title services to the customers of homebuilding operations. Homebuilding operations comprise a predominant portion of the revenue. The company builds homes and communities that target entry-level, move-up, and luxury homebuyers.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: